A review article published in Modern Chemotherapy (scientific publication) in April 2013 shows the effectiveness of Curaderm BEC5 when treating nonmalignant and very malignant skin lesions. This study also shows the global interest in the active anticancer ingredients and their potential for the treatment of aggressive internal cancers. To read the published article please see link: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=30489
